Free Webinar: How will quality management change by 2025?
July 3, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, Webinar, veeva
Following on from the success of our previous free webinar sessions, Pharmafocus is partnering
NICE recommends AstraZeneca lung treatment
July 3, 2017Sales and Marketing AstraZeneca, Daxas, NICE
AstraZeneca’s Daxas (roflumilast) has received recommendation from NICE for the treatment of chronic obstructive pulmonary disease (COPD) it has emerged, …
Pricing Consultant Job Profile and Description
June 30, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GPI
Pricing Consultant Job Profile and Description About Global Pricing Innovations (GPI)
Head of Product Innovation Job Profile and Description
June 30, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GPI
Head of Product Innovation Job Profile and Description About Global Pricing Innovations (GPI)
Development Manager Job Profile and Description
June 30, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GPI
Development Manager Job Profile and DescriptionGPI is a global pricing consultancy launching products, services and offerings that make a measurable …
ABPI reveals 10% increase in HCP payment disclosure
June 30, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Astellas, disclosure, disclosure uk
The headline news from the ABPI’s press conference on Disclosure UK was that healthcare professionals’ (HCPs) disclosure of payments for …
Eli Lilly arthritis drug outperforms Humira and receives NICE backing
June 30, 2017Medical Communications, Research and Development, Sales and Marketing Eli Lilly, NICE, Olumiant, rheumatoid arthritis
Eli Lilly’s rheumatoid arthritis (RA) drug Olumiant (baricitinib) has been deemed cost-effective by NICE and has been recommended to be …
The pharmaceutical research and development challenge
June 30, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing R&D, pharmafile
This report from Kalorama Information was featured in the Spring 2017 edition of Pharmafile. Despite new approaches, new technologies and …
Top Ten most popular articles on Pharmafile.com this week
June 30, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
It’s Friday, and we’ve brought together our weekly digest of the articles which proved most popular with our readers. Mylan …
‘He was born this way’, Shkreli case becomes circus
June 29, 2017Medical Communications Martin Shkreli, Shkreli, Turing Pharmaceutical, turing
Martin Shkreli’s Attorney, Benjamin Brafman, defended his client in a bizarre reference to a pop singer, “As Lady Gaga would …
American Cancer Society and Melanoma Research Alliance join forces to bring down immunotherapy side-effects
June 29, 2017Medical Communications, Research and Development American Cancer Society, Cancer, Melanoma Research Alliance, immunotherapy
The American Cancer Society (ACS) and the Melanoma Research Alliance (MRA) have formed a research partnership to reduce the impact …
Sarepta appoints ex-Allergan President as new CEO
June 29, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sarepta Therapeutics
Sarepta Therapeutics has announced the appointment of ex-Allergan President Doug Ingram as the company’s new CEO – it’s third in …
Regulators get aggressive on matters excessive
June 29, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CMA, Drug pricing, European Commission, Pfizer, aspen
Gustaf Duhs, Partner at Stevens & Bolton, discusses the recent cases of regulators becoming firmer with drug companies over their …
Investors demand resignation of Mylan executives over pay packages
June 29, 2017Sales and Marketing Heather Bresch, Mylan, epipen
As confidence in Mylan continues to fall and share prices plummet after last year’s EpiPen pricing scandal and subsequent PR …
Novartis gains first-line approval for Zykadia in lung cancer
June 29, 2017Research and Development EMA, European Commission, NSCLC, Novartis
The European Commission has followed the EMA’s CHMP positive opinion by approving Novartis’ Zykadia for first-line treatment of patients with …
Investigational antibody boosts chemotherapy’s cancer-killing potential
June 29, 2017Research and Development CFH, Cancer, oncology, rituximab
A proof-of-concept study conducted at the Duke Cancer Institute (DCI) in North Carolina has shown that an investigational antibody has …
Enzyme able to untangle protein aggregates associated with Alzheimer’s
June 29, 2017Research and Development Alzheimer's, Parkinson's
There are currently no effective treatments for neurodegenerative disorders, such as Alzheimer’s and Parkinson’s disease. This is presently a pressing …
Researchers in world-first study on antibiotic use for sepsis
June 28, 2017Research and Development NHS, antibiotic, sepsis
The University of Warwick, alongside the University of Manchester, are launching a world-first study aimed at determining the length of …
Regenacy names new President and CEO
June 28, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Regenacy, appointment
Simon S Jones has been revealed as the new President and Chief Executive Officer of Regenacy Pharmaceuticals, a biopharma company …
Myeloma UK’s new CEO begins her role
June 28, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Myeloma UK
Myeloma UK, the only organisation in the UK dealing exclusively with myeloma, will have a new CEO in place from …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
